WO2002053574A3 - Molecules pna modifiees - Google Patents
Molecules pna modifiees Download PDFInfo
- Publication number
- WO2002053574A3 WO2002053574A3 PCT/DK2002/000005 DK0200005W WO02053574A3 WO 2002053574 A3 WO2002053574 A3 WO 2002053574A3 DK 0200005 W DK0200005 W DK 0200005W WO 02053574 A3 WO02053574 A3 WO 02053574A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pna
- nucleic acid
- peptide nucleic
- modified
- amino acid
- Prior art date
Links
- 108091093037 Peptide nucleic acid Proteins 0.000 abstract 9
- PIINGYXNCHTJTF-UHFFFAOYSA-N 2-(2-azaniumylethylamino)acetate Chemical compound NCCNCC(O)=O PIINGYXNCHTJTF-UHFFFAOYSA-N 0.000 abstract 1
- WRXNJTBODVGDRY-UHFFFAOYSA-N 2-pyrrolidin-1-ylethanamine Chemical compound NCCN1CCCC1 WRXNJTBODVGDRY-UHFFFAOYSA-N 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- -1 aminoethylprolyl Chemical group 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002216946A AU2002216946A1 (en) | 2001-01-05 | 2002-01-03 | Modified pna molecules |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200100021 | 2001-01-05 | ||
DKPA200100021 | 2001-01-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002053574A2 WO2002053574A2 (fr) | 2002-07-11 |
WO2002053574A3 true WO2002053574A3 (fr) | 2002-10-24 |
Family
ID=8159969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DK2002/000005 WO2002053574A2 (fr) | 2001-01-05 | 2002-01-03 | Molecules pna modifiees |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002216946A1 (fr) |
WO (1) | WO2002053574A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10370415B2 (en) | 2013-04-11 | 2019-08-06 | Carnegie Mellon University | Divalent nucleobase compounds and uses therefor |
WO2014169216A2 (fr) | 2013-04-11 | 2014-10-16 | Carnegie Mellon University | Synthèse de γpna dirigée par une matrice et composés ciblant γpna |
JP7573965B2 (ja) | 2016-09-26 | 2024-10-28 | カーネギー メロン ユニバーシティ | 二価核酸塩基化合物およびそれらの使用 |
US20230242587A1 (en) * | 2020-04-17 | 2023-08-03 | The United States Of America,As Represented By The Secretary,Department Of Health And Human Services | Thyclotides |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016550A1 (fr) * | 1996-10-14 | 1998-04-23 | Isis Innovation Limited | Acides nucleiques chiraux de peptide |
WO1998052614A2 (fr) * | 1997-05-21 | 1998-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Composition et procede permettant d'ameliorer les transports a travers des membranes biologiques |
WO1999005302A1 (fr) * | 1997-07-24 | 1999-02-04 | The Perkin-Elmer Corporation | Conjugues de peptides transporteurs et analogues d'acides nucleiques ainsi que leur utilisation |
WO2000040742A1 (fr) * | 1999-01-08 | 2000-07-13 | Amaxa Gmbh | Utilisation de systemes de transport propres aux cellules pour transferer des acides nucleiques a travers l'enveloppe nucleaire |
WO2001027261A2 (fr) * | 1998-11-11 | 2001-04-19 | Pantheco A/S | Conjugues entre un peptide et un analogue d'acide nucleique tel que anp, anl ou une morpholine |
WO2001076636A2 (fr) * | 2000-04-06 | 2001-10-18 | Pantheco A/S | Composition pharmaceutique a base de molecules de pna modifiees |
-
2002
- 2002-01-03 WO PCT/DK2002/000005 patent/WO2002053574A2/fr not_active Application Discontinuation
- 2002-01-03 AU AU2002216946A patent/AU2002216946A1/en not_active Abandoned
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998016550A1 (fr) * | 1996-10-14 | 1998-04-23 | Isis Innovation Limited | Acides nucleiques chiraux de peptide |
WO1998052614A2 (fr) * | 1997-05-21 | 1998-11-26 | The Board Of Trustees Of The Leland Stanford Junior University | Composition et procede permettant d'ameliorer les transports a travers des membranes biologiques |
WO1999005302A1 (fr) * | 1997-07-24 | 1999-02-04 | The Perkin-Elmer Corporation | Conjugues de peptides transporteurs et analogues d'acides nucleiques ainsi que leur utilisation |
WO2001027261A2 (fr) * | 1998-11-11 | 2001-04-19 | Pantheco A/S | Conjugues entre un peptide et un analogue d'acide nucleique tel que anp, anl ou une morpholine |
WO2000040742A1 (fr) * | 1999-01-08 | 2000-07-13 | Amaxa Gmbh | Utilisation de systemes de transport propres aux cellules pour transferer des acides nucleiques a travers l'enveloppe nucleaire |
WO2001076636A2 (fr) * | 2000-04-06 | 2001-10-18 | Pantheco A/S | Composition pharmaceutique a base de molecules de pna modifiees |
Non-Patent Citations (14)
Title |
---|
BASU S ET AL: "SYNTHESIS AND CHARACTERIZATION OF A PEPTIDE NUCLEIC AICD CONJUGATED TO A D-PEPTIDE ANALOG OF INSULIN-LIKE GROWTH FACTOR 1 FOR INCREASED CELLULAR UPTAKE", BIOCONJUGATE CHEMISTRY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, US, vol. 8, no. 8, 1997, pages 481 - 488, XP002902380, ISSN: 1043-1802 * |
GANGAMANI B P ET AL: "SPERMINE CONJUGATED PEPTIDE NUCLEIC ACIDS (SPPNA): UV AND FLUORESCENCE STUDIES OF PNA-DNA HYBRIDS WITH IMPROVED STABILITY", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 240, no. 3, 1997, pages 778 - 782, XP002902382, ISSN: 0006-291X * |
HARRISON J G ET AL: "INHIBITION OF HUMAN TELOMERASE BY PNA-CATIONIC PEPTIDE CONJUGATES", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 9, 1999, pages 1273 - 1278, XP002901880, ISSN: 0960-894X * |
ISHIHARA ET AL: "Rules for Strand Invasion by Chemically Modified Oligonucleotides", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, vol. 121, no. 10, 1999, pages 2012 - 2020, XP002140165, ISSN: 0002-7863 * |
JORDAN S ET AL: "Synthesis of new building blocks for peptide nucleic acids containing monomers with variations in the backbone", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 7, no. 6, 18 March 1997 (1997-03-18), pages 681 - 686, XP004136108, ISSN: 0960-894X * |
KUMAR V ET AL: "PYRROLIDINE NUCLEIC ACIDS: DNA/PNA OLIGOMERS WITH 2-HYDROXY/AMINOMETHYL-4-(THYMIN-1-YL)PYRROLIDINE-N-ACETIC ACID", ORGANIC LETTERS, ACS, WASHINGTON, DC, US, vol. 9, no. 3, 2001, pages 1269 - 1272, XP002902385, ISSN: 1523-7060 * |
MONEESHA D'COSTA ET AL: "Aminoethylprolyl (aep) PNA: Mixed purine/pyrimidine oligomers and binding orientation preferences for PNA:DNA duplex formation.", ORGANIC LETTERS, vol. 3, no. 9, 2001, pages 1281 - 1284, XP002902588 * |
MONEESHA D'COSTA ET AL: "Aminoethylprolyl peptide nucleic acids (aepPNA): Chiral PNA analogues that form highly stable DNA:aepPNA2 triplexes.", ORGANIC LETTERS, vol. 1, no. 10, 1999, pages 1513 - 1516, XP002902586 * |
PUSCHL A ET AL: "Peptide Nucleic Acids (PNAs) with a Functional Backbone", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 39, no. 26, 25 June 1998 (1998-06-25), pages 4707 - 4710, XP004130902, ISSN: 0040-4039 * |
PÜSCHL A ET AL: "Peptide nucleic acids with a constrained cyclic backbone.", INNOVATION AND PERSPECTIVES IN SOLID PHASE SYNTHESIS & COMBINATONAL LIBRARIES, 6TH INTERNATIONAL SYMPOSIUM, 31 August 1999 (1999-08-31), YORK, ENGLAND EDITOR R. EPTON, MAYFLOWER WORLDWIDE LTD 2000, pages 343 - 346, XP002902585 * |
PUSCHL A ET AL: "Pyrrolidine PNA: A novel conformationally restricted PNA analogue.", ORGANIC LETTERS, vol. 2, no. 26, 2000, pages 4161 - 4163, XP002902587 * |
SIMMONS C G ET AL: "Synthesis and membrane permeability of pna-peptide conjugates", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 7, no. 23, 2 December 1997 (1997-12-02), pages 3001 - 3006, XP004136573, ISSN: 0960-894X * |
VILAIVAN T ET AL: "Synthesis and properties of chiral peptide nucleic acids with a N-Aminoethyl-d-proline backbone", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, OXFORD, GB, vol. 10, no. 22, 20 November 2000 (2000-11-20), pages 2541 - 2545, XP004224259, ISSN: 0960-894X * |
VILAIVAN T ET AL: "Synthesis and properties of novel pyrrolidinyl PNA carrying beta-amino acid spacers", TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 42, no. 32, 6 August 2001 (2001-08-06), pages 5533 - 5536, XP004255002, ISSN: 0040-4039 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002053574A2 (fr) | 2002-07-11 |
AU2002216946A1 (en) | 2002-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002090503A3 (fr) | Peptides antimicrobiens et compositions | |
WO2002059306A3 (fr) | Proteines transporteuses humaines isolees, molecules d'acide nucleique codant des proteines transporteuses humaines et leurs utilisations | |
WO2001046260A3 (fr) | Nouveaux membres de la superfamille des immunoglobulines apex-1, apex-2 et apex-3 et leurs utilisations | |
WO2002095049A3 (fr) | Proteines isolees secretees par l'humain, molecules d'acides nucleiques codant pour ces proteines secretees par l'humain et leur utilisation | |
WO2002042316A3 (fr) | Analogues de proteine pna | |
WO2002053574A3 (fr) | Molecules pna modifiees | |
WO2002026947A3 (fr) | Proteines proteases humaines isolees, molecules d'acide nucleique codant ces proteines, et utilisation de ces proteines | |
WO2003006671A3 (fr) | Proteines humaines secretees et isolees, molecules d'acide nucleique codant les proteines humaines secretees et utilisation de ces dernieres | |
WO2002006315A3 (fr) | Sequences d'acides nucleiques et d'acides amines | |
PL356055A1 (en) | Dna sequence and recombinant production of a graminae allergen | |
RS26004A (en) | Aromatic and heteroaromatic acid halides for synthesizing polyamides | |
WO2003027314A3 (fr) | Composes de liaison proteges | |
WO2002016566A3 (fr) | Proteines proteasiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines proteasiques humaines, et utilisations correspondantes | |
WO2001092490A3 (fr) | Proteines humaines isolees d'aminotransferase, molecules d'acide nucleique codant des proteines humaines d'aminotransferase, et leurs utilisations | |
WO2002079405A3 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant pour ces proteines, et leurs utilisations | |
WO2002050286A3 (fr) | Proteines proteases humaines isolees, molecules d'acide nucleique codant ces proteines, et utilisation de ces proteines | |
WO2002077164A3 (fr) | Aminoacylase humaine isolee, molecules d'acide nucleique codant l'aminoacylase humaine, et leurs utilisations | |
WO2002074974A3 (fr) | Proteines enzymatiques humaines isolees, molecules d'acide nucleique codant lesdites proteines et utilisations associees | |
WO2002079430A3 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant des proteines enzymatiques humaines, et utilisations associees | |
WO2003033725A3 (fr) | Proteines enzymatiques humaines isolees, molecules d'acides nucleiques codant des proteines enzymatiques humaines et utilisations de celles-ci | |
WO2002083914A3 (fr) | Proteines humaines secretees isolees, molecules d'acide nucleique codant des proteines humaines secretees et utilisations associees | |
WO2003006483A3 (fr) | Proteines secretees humaines isolees, molecules d'acide nucleique codantes pour ces proteines secretees humaines et utilisations de celles-ci | |
WO2001081413A3 (fr) | Proteines de transport humaines isolees, molecules d'acides nucleiques codant pour les proteines de transport humaines et utilisations associees | |
WO2002077167A3 (fr) | Proteines isolees humaines de la protease, molecules d'acide nucleique codant les proteines humaines de la protease et leurs utilisations | |
WO2002077166A3 (fr) | Proteines proteases humaines isolees, molecules d'acide nucleique codant des proteines proteases humaines et leurs utilisations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |